Menu Search
Equities

Hologic Inc

HO1:BRN

Hologic Inc

Actions
  • Price (CHF)74.76
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Feb 08 2021.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. It also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.

  • Revenue in USD (TTM)4.03bn
  • Net income in USD789.50m
  • Incorporated1990
  • Employees6.99k
  • Location
    Hologic Inc250 Campus DriveMARLBOROUGH 1752United StatesUSA
  • Phone+1 (508) 263-2900
  • Fax+1 (302) 655-5049
  • Websitehttps://www.hologic.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		HOLX:NSQ since
announced		Transaction
value
Gynesonics IncAnnounced14 Oct 202414 Oct 2024Announced-1.52%350.00m
Endomagnetics LtdDeal completed29 Apr 202429 Apr 2024Deal completed3.44%--
Data delayed at least 15 minutes, as of Nov 21 2024 20:23 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.